Titre : | Screening and diagnosis of anxiety and mood disorders in substance abuse patients |
Titre traduit : | (Dépistage et diagnostic de l'anxiété et des troubles de l'humeur chez des patients usagers de drogues.) |
Auteurs : | I. H. A. FRANKEN ; V. M. HENDRIKS |
Type de document : | Périodique |
Année de publication : | 2001 |
Format : | 30-39 / graph. ; tabl. |
Note générale : |
American Journal on Addictions, 2001, 10, (1), 30-39 |
Langues: | Anglais |
Discipline : | TRA (Traitement et prise en charge / Treatment and care) |
Mots-clés : |
Thésaurus mots-clés PSYCHOPATHOLOGIE ; DIAGNOSTIC ; TEST ; ORIENTATION ; TRAITEMENT ; EFFICACITE ; ETUDE PROSPECTIVEThésaurus géographique PAYS-BAS |
Résumé : |
ENGLISH : The aims of this study are (1) to study the prevalence of anxiety and mood disorders in a clinical substance abuse population, (2) to asses the pre-and post-detoxification change in SCL-90 score in this population for subjects with psychopathology compared to subjects without psychopathology, and (3) to asses the value of the SCL-90 and the Addiction Severity Index-psychiatric problems scale as clinical diagnostic screening instrument for psycbopathology. The design was a longitudinal prospective cohort study with pre-detoxification ASI and SCL-90 data and post-detoxification CIDI and SCL-90 data on a clinical sample of 116 substance abuse patients. The present results indicate that the ASI-Psychiatric problems score is a limited indicator of psychiatric comorbidity. When a pre-detoxification screening for psychopathology is warranted, the present results show that the use of the SCL-90 is preferable above the ASI-PSY scale. Of the screening scores under study, the post-detoxification SCL-90 score is found to be the most valid screening instrument for diagnosis of anxiety and mood disorders in a clinical substance abuse population. Although the post-detoxification SCL-90 score holds moderate specificity combined whith high sensitivity, applying this instrument in clinical substance abuse practice will result in a substantial reduction of patients unnecessarily referred for further psychiatric diagnostic evaluation. Further studies aimed at improvement of screening instruments in this population are needed. (Author' s abstract) |
Note de contenu : | graph. ; tabl. |
Domaine : | Drogues illicites / Illicit drugs |
Refs biblio. : | 33 |
Affiliation : |
Parnassia Psychiatric Centre, Parnassia Addiction Research Centre (PARC), P.O Box 53002, 2505 AA The Hague. Email : i.franken@parnassia.nl Pays-Bas. Netherlands. |
Numéro Toxibase : | 205599 |
Centre Emetteur : | 02 Coordonnateur |
Exemplaires
Disponibilité |
---|
aucun exemplaire |
Accueil